Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 3/15/16 → 8/8/24 |
Financiación
- Intercept Pharmaceuticals Incorporated: 287.451,00 US$
A Phase 3, Double-Blind, Randomized, Long Term, Placebo-Controlled Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis
- Grigorian, Alla (PI)
- Leyson, Christina (CoI)